Cite
HARVARD Citation
de Vries, R. et al. (2018). Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara–Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial. Journal of infectious diseases. pp. 614-623. [Online].